Discover
CLOV
Clover Health Investments, Corp.
5.39
2 x 3.94
2 x 6.65
bid
ask
+
0.15
2.86%
2 @ 05:37 AM
5.40 +0.01 (0.19%)
| Ytd | 129.36% | |
| 1y | 96.00% |
5.12
day range
5.54
1.58
52 week range
5.59
| Open | 5.25 | Prev Close | 5.24 | Low | 5.12 | High | 5.54 | Mkt Cap | 2.84B |
| Vol | 7.85M | Avg Vol | 7.67M | EPS | -0.12 | P/E | N/A | Forward P/E | 52.40 |
| Beta | 2.48 | Short Ratio | 2.66 | Inst. Own | 30.01% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 3.80 | 200-d Avg | 2.80 | 1yr Est | 4.15 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2026-05-06 | 2026-03 | 0.07 | 0.07 | N/A | N/A |
| 2026-02-26 | 2025-12 | 0 | N/A | N/A | N/A |
| 2026-02-26 | 2025-12 | 0 | N/A | N/A | N/A |
| 2025-11-04 | 2025-09 | 0.02 | N/A | N/A | N/A |
| 2025-11-04 | 2025-09 | 0.02 | N/A | N/A | N/A |
| 2025-08-05 | 2025-06 | 0.03 | 0.03 | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2026-06-11 | UBS | Upgrade | Neutral | Neutral |
| 2026-06-04 | Canaccord Genuity | Upgrade | Buy | Buy |
| 2026-03-20 | Canaccord Genuity | Upgrade | Buy | Buy |
| 2026-03-05 | Leerink Partners | Upgrade | Market Perform | Market Perform |
| 2026-01-20 | Canaccord Genuity | Upgrade | Buy | Buy |
| 2025-11-06 | Canaccord Genuity | Upgrade | Buy | Buy |
Profile
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2025-01-05 | CLINTON CHELSEA | Director | 602.81K | Stock Award(Grant) |
| 2026-01-06 | GARIPALLI VIVEK | Director and Beneficial Owner of more than 10% of a Class of Security | 1.86M | Conversion of Exercise of derivative security |
| 2026-01-05 | KOUZOUKAS DEMETRIOS L | Director | 605.98K | Stock Award(Grant) |
| 2025-05-18 | KUIPERS PETER J | Chief Financial Officer | 6.35M | Stock Award(Grant) |
| 2026-05-12 | PRIEST BRADY PATRICK | Officer | 2.04M | Sale |
| 2026-06-16 | REYNOSO JAMIE L. | Officer | 2.84M | Sale |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2026-03-30 | Blackrock Inc. | 31.84M | 171.62M | 7.39% |
| 2026-03-30 | Vanguard Capital Management LLC | 16.98M | 91.53M | 3.94% |
| 2026-03-30 | Geode Capital Management, LLC | 10.06M | 54.20M | 2.33% |
| 2026-03-30 | State Street Corporation | 9.56M | 51.53M | 2.22% |
| 2026-03-30 | Charles Schwab Investment Management, Inc. | 5.30M | 28.57M | 1.23% |
| 2026-03-30 | PNC Financial Services Group, Inc. | 3.76M | 20.29M | 0.87% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2026-03-30 | VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 12.06M | 65.02M | 2.80% |
| 2026-04-29 | iShares Trust-iShares Russell 2000 ETF | 9.62M | 51.85M | 2.23% |
| 2026-03-30 | VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 4.46M | 24.05M | 1.04% |
| 2026-04-29 | Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 4.04M | 21.78M | 0.94% |
| 2026-04-29 | iShares Trust-iShares Russell 2000 Growth ETF | 3.36M | 18.11M | 0.78% |
| 2026-04-29 | Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 2.15M | 11.60M | 0.50% |
Dividend
| Dividend | Date |
|---|---|
| 0.1 | 2021-08-23 |